Literature DB >> 25619835

Understanding the Polo Kinase machine.

V Archambault1, G Lépine1, D Kachaner1.   

Abstract

The Polo Kinase is a central regulator of cell division required for several events of mitosis and cytokinesis. In addition to a kinase domain (KD), Polo-like kinases (Plks) comprise a Polo-Box domain (PBD), which mediates protein interactions with targets and regulators of Plks. In all organisms that contain Plks, one Plk family member fulfills several essential functions in the regulation of cell division, and here we refer to this conserved protein as Polo Kinase (Plk1 in humans). The PBD and the KD are capable of both cooperation and mutual inhibition in their functions. Crystal structures of the PBD, the KD and, recently, a PBD-KD complex have helped understanding the inner workings of the Polo Kinase. In parallel, an impressive array of molecular mechanisms has been found to mediate the regulation of the protein. Moreover, the targeting of Polo Kinase in the development of anti-cancer drugs has yielded several molecules with which to chemically modulate Polo Kinase to study its biological functions. Here we review our current understanding of the protein function and regulation of Polo Kinase as a fascinating molecular device in control of cell division.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25619835     DOI: 10.1038/onc.2014.451

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  121 in total

Review 1.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

2.  Cdc28-dependent regulation of the Cdc5/Polo kinase.

Authors:  Eric M Mortensen; Wilhelm Haas; Melanie Gygi; Steven P Gygi; Douglas R Kellogg
Journal:  Curr Biol       Date:  2005-11-22       Impact factor: 10.834

3.  Exploring Potential Binding Modes of Small Drug-like Molecules to the Polo-Box Domain of Human Polo-like Kinase 1.

Authors:  Chenzhong Liao; Jung-Eun Park; Jeong Kyu Bang; Marc C Nicklaus; Kyung S Lee
Journal:  ACS Med Chem Lett       Date:  2010       Impact factor: 4.345

Review 4.  Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity.

Authors:  Ravichandran N Murugan; Jung-Eun Park; Eun-Hee Kim; Song Yub Shin; Chaejoon Cheong; Kyung S Lee; Jeong Kyu Bang
Journal:  Mol Cells       Date:  2011-07-29       Impact factor: 5.034

5.  The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.

Authors:  Péter Lénárt; Mark Petronczki; Martin Steegmaier; Barbara Di Fiore; Jesse J Lipp; Matthias Hoffmann; Wolfgang J Rettig; Norbert Kraut; Jan-Michael Peters
Journal:  Curr Biol       Date:  2007-02-08       Impact factor: 10.834

6.  Polo-like kinase-2 is required for centriole duplication in mammalian cells.

Authors:  Silke Warnke; Stefan Kemmler; Rebecca S Hames; Hsiao-Lun Tsai; Urs Hoffmann-Rohrer; Andrew M Fry; Ingrid Hoffmann
Journal:  Curr Biol       Date:  2004-07-13       Impact factor: 10.834

7.  Binding of Drosophila Polo kinase to its regulator Matrimony is noncanonical and involves two separate functional domains.

Authors:  Amanda M Bonner; Stacie E Hughes; Jennifer A Chisholm; S Kendall Smith; Brian D Slaughter; Jay R Unruh; Kimberly A Collins; Jennifer M Friederichs; Laurence Florens; Selene K Swanson; Marissa C Pelot; Danny E Miller; Michael P Washburn; Sue L Jaspersen; R Scott Hawley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

8.  Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells.

Authors:  Elizabeth M Matthew; Timothy J Yen; David T Dicker; Jay F Dorsey; Wensheng Yang; Arunasalam Navaraj; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2007-09-25       Impact factor: 4.534

9.  Structural basis for the inhibition of Polo-like kinase 1.

Authors:  Jun Xu; Chen Shen; Tao Wang; Junmin Quan
Journal:  Nat Struct Mol Biol       Date:  2013-07-28       Impact factor: 15.369

Review 10.  The decision to enter mitosis: feedback and redundancy in the mitotic entry network.

Authors:  Arne Lindqvist; Verónica Rodríguez-Bravo; René H Medema
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

View more
  61 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

3.  Cdk1 plays matchmaker for the Polo-like kinase and its activator SPAT-1/Bora.

Authors:  Nicolas Tavernier; Costanza Panbianco; Monica Gotta; Lionel Pintard
Journal:  Cell Cycle       Date:  2015-06-03       Impact factor: 4.534

4.  PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.

Authors:  Yuan Ren; Chengfeng Bi; Xiaohong Zhao; Tint Lwin; Cheng Wang; Ji Yuan; Ariosto S Silva; Bijal D Shah; Bin Fang; Tao Li; John M Koomen; Huijuan Jiang; Julio C Chavez; Lan V Pham; Praneeth R Sudalagunta; Lixin Wan; Xuefeng Wang; William S Dalton; Lynn C Moscinski; Kenneth H Shain; Julie Vose; John L Cleveland; Eduardo M Sotomayor; Kai Fu; Jianguo Tao
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

5.  Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay.

Authors:  Karine Normandin; Jean-François Lavallée; Marie Futter; Alexandre Beautrait; Jean Duchaine; Sébastien Guiral; Anne Marinier; Vincent Archambault
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

6.  Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation.

Authors:  Xueyan Li; Shanshan Nai; Yuehe Ding; Qizhi Geng; Bingtao Zhu; Kai Yu; Wei-Guo Zhu; Meng-Qiu Dong; Xiao-Dong Su; Xingzhi Xu; Jing Li
Journal:  Cell Cycle       Date:  2017-08-18       Impact factor: 4.534

7.  Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2017-02-28       Impact factor: 3.641

Review 8.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

9.  Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2016-09-02       Impact factor: 2.823

10.  Reduced kinase activity of polo kinase Cdc5 affects chromosome stability and DNA damage response in S. cerevisiae.

Authors:  Chetan C Rawal; Sara Riccardo; Chiara Pesenti; Matteo Ferrari; Federica Marini; Achille Pellicioli
Journal:  Cell Cycle       Date:  2016-08-26       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.